Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiwei Ling

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Computational and Structural Biotechnology Journal|June 30, 2021
Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancerShujiro Okuda, Yoshifumi Shimada, Yosuke Tajima, et al.
Scientific Reports|February 23, 2019
BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancerYoshifumi Shimada, Yusuke Muneoka, Masayuki Nagahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2016
[New Classification for Advanced Colorectal Cancer Using CancerPlex®Genomic Tests]Hitoshi Kameyama, Yoshifumi Shimada, Hiroshi Ichikawa, et al.
Histopathology|January 13, 2019
SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancerHidehito Oyanagi, Yoshifumi Shimada, Masayuki Nagahashi, et al.
Oncology Reports|April 3, 2020
RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancerAkio Matsumoto, Yoshifumi Shimada, Mae Nakano, et al.
Microorganisms|April 23, 2022
Putrescine Production by <i>Latilactobacillus curvatus</i> KP 3-4 Isolated from Fermented FoodsRika Hirano, Aiko Kume, Chisato Nishiyama, et al.
Journal of Gastroenterology|April 28, 2021
Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancerYoshifumi Shimada, Shujiro Okuda, Yu Watanabe, et al.
Breast Cancer (Tokyo, Japan)|January 14, 2025
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapyMasayuki Nagahashi, Eri Ishikawa, Takahiro Nagai, et al.
Translational Oncology|August 23, 2022
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcomaYudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2026
NKG2D-based CAR-T cells for synovial sarcoma: A preclinical proof-of-concept studyTomohiro Miyazaki, Yudai Murayama, Naoki Oike, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Computational and Structural Biotechnology Journal|June 30, 2021
Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancerShujiro Okuda, Yoshifumi Shimada, Yosuke Tajima, et al.
Scientific Reports|February 23, 2019
BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancerYoshifumi Shimada, Yusuke Muneoka, Masayuki Nagahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2016
[New Classification for Advanced Colorectal Cancer Using CancerPlex®Genomic Tests]Hitoshi Kameyama, Yoshifumi Shimada, Hiroshi Ichikawa, et al.
Histopathology|January 13, 2019
SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancerHidehito Oyanagi, Yoshifumi Shimada, Masayuki Nagahashi, et al.
Oncology Reports|April 3, 2020
RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancerAkio Matsumoto, Yoshifumi Shimada, Mae Nakano, et al.
Microorganisms|April 23, 2022
Putrescine Production by <i>Latilactobacillus curvatus</i> KP 3-4 Isolated from Fermented FoodsRika Hirano, Aiko Kume, Chisato Nishiyama, et al.
Journal of Gastroenterology|April 28, 2021
Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancerYoshifumi Shimada, Shujiro Okuda, Yu Watanabe, et al.
Breast Cancer (Tokyo, Japan)|January 14, 2025
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapyMasayuki Nagahashi, Eri Ishikawa, Takahiro Nagai, et al.
Translational Oncology|August 23, 2022
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcomaYudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2026
NKG2D-based CAR-T cells for synovial sarcoma: A preclinical proof-of-concept studyTomohiro Miyazaki, Yudai Murayama, Naoki Oike, et al.
Pageof 5